Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Allium Medical Solutions Ltd is 'Not Rated'. Macroaxis provides Allium Medical buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALMD positions. The advice algorithm takes into account all of Allium Medical Solutions available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ALMD buy-and-hold prospective. Check also Trending Equities.
For the selected time horizon Allium Medical Solutions Ltd has a risk adjusted performance of (0.16), jensen alpha of (1.09), total risk alpha of (1.89), sortino ratio of 0.0 and treynor ratio of 1.01Macroaxis provides unbiased buy, hold, or sell recommendation on Allium Medical Solutions that should be used to complement current analysts and expert consensus on Allium Medical Solutions Ltd. Our buy or sell advice engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Allium Medical is not overpriced, please confirm all Allium Medical Solutions fundamentals including its Price to Book, Revenue and the relationship between Price to Earning and Price to Sales .
Allium Medical Returns Distribution Density
|Mean Return||1.2||Value At Risk||14.41|
|Potential Upside||5.21||Standard Deviation||5.02|
|Allium Medical is not yet fully synchronised with the market data|
|Allium Medical has high likelihood to experience some financial distress in the next 2 years|
|The company reported revenue of 8.86M. Net Loss for the year was (24.64M) with profit before overhead, payroll, taxes, and interest of 2.02M.|
|ALLIUM MEDIC SOLU has accumulated about 16.61M in cash with (18.16M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.|